Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07493603
Eligibility Criteria:
Inclusion Criteria:
All of the following conditions must be met simultaneously for enrollment:
* ① Meet the diagnostic criteria for stable angina pectoris;
* ② Classified as Grade I to III according to the Canadian Cardiovascular Society (CCS) Angina Grading Scale;
* ③ Meet the diagnostic criteria for chest discomfort syndrome due to yang qi deficiency and decline (a traditional Chinese medicine pattern differentiation);
* ④ Aged between 50 and 75 years old;
* ⑤ Received drug-eluting stent implantation due to severe vascular stenosis (single artery ≥75%， or LM ≥50%) detected by coronary angiography;
* ⑥ Able to actively comply with medical instructions and voluntarily sign the written informed consent form.
Exclusion Criteria:
Participants will be excluded if they meet any of the following conditions:
* ① Diagnosed with acute coronary syndrome (including acute ST-segment elevation myocardial infarction, acute non-ST-segment elevation myocardial infarction, and unstable angina pectoris) after relevant examinations;
* ② Suffer from chest pain caused by non-cardiac diseases other than stable angina pectoris; or have complicated severe hypertension (systolic blood pressure ≥ 180mmHg and/or diastolic blood pressure ≥ 110mmHg), severe cardiopulmonary insufficiency, or malignant tumor;
* ③ Have severe endocrine, hematological or rheumatic immune system diseases, severe hepatic and renal dysfunction, active gastrointestinal bleeding, or mental illness;
* ④ Have an allergic constitution or a history of allergic reactions to traditional Chinese medicine;
* ⑤ Have incomplete major baseline data that may affect the trial results, or have participated in other clinical trials recently.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
75 Years
Study:
NCT07493603
Study Brief:
Protocol Section:
NCT07493603